Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.

BJU international - 1 Dec 2013

Wieczorek Edyta, Reszka Edyta, Jablonowski Zbigniew, Jablonska Ewa, Krol Magdalena Beata, Grzegorczyk Adam, Gromadzinska Jolanta, Sosnowski Marek, Wasowicz Wojciech

Abstract excerpt

OBJECTIVES: To elucidate genetic polymorphisms of the matrix metalloproteinases (MMPs) MMP1 (rs1799750), MMP2 (rs243865), MMP9 (rs3918242), MMP12 (rs2276109) and tissue inhibitors of MMPs (TIMPs) TIMP1 (rs2070584) and TIMP3 () genes that may be involved in susceptibility to bladder cancer (BC). PATIENTS AND METHODS: We enrolled 241 patients with BC and 199 controls. Genomic DNA samples were extracted...

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to Matrix Metalloproteinase 1
Share to Odds Ratio
Share to Poland
Share to Real-Time Polymerase Chain Reaction
Share to Smoking
Share to Tissue Inhibitor of Metalloproteinase-1
Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 23819551
DOI: 10.1111/bju.12230

Genes

MMP1
MMP2
MMP9
MMP12
TIMP1
TIMP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.PMID 23819551Read ↗

Matrix metalloproteinase polymorphisms and bladder cancer risk.Semantic proximity Read ↗

Insights From Matrix Metalloproteinase-2 Genotypes to Decipher the Genetic Architecture of Bladder Cancer Risk.Semantic proximity Read ↗

Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population.Semantic proximity Read ↗

Bladder Cancer Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1 and 7 in North Indian PopulationSemantic proximity Read ↗

The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.Semantic proximity Read ↗

Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Semantic proximity Read ↗

MMP7 and MMP8 genetic polymorphisms in bladder cancer patientsSemantic proximity Read ↗

Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.Semantic proximity Read ↗

Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.Semantic proximity Read ↗

Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.Semantic proximity Read ↗

MMP2 gene polymorphism and tumor susceptibility studySemantic proximity Read ↗

Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.